C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2002
11/07/2002	US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002	US20020165349 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorder and alzheimer's disease
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002	US20020165177 Modified factor VIII cDNA
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165151 Promoting smooth muscle cell growth or vasculogenesis with an antibody that reacts with the protein
11/07/2002	US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002	US20020165143 Identification and isolation of novel DNA
11/07/2002	US20020165137 Diagnosing, treating, preventing and/or prognosing disorders related to these polypeptides
11/07/2002	US20020164787 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
11/07/2002	US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002	US20020164767 DNA encoding the human serine protease C-E
11/07/2002	US20020164747 Gene cluster for ramoplanin biosynthesis
11/07/2002	US20020164743 Novel cytidine deaminase
11/07/2002	US20020164738 Cell death inhibitory protein
11/07/2002	US20020164734 Human pelota homolog
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164711 Megakaryocyte differentiation factor
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002	US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002	US20020164700 Metabolic rate shifts in fermentations expressing recombinant proteins
11/07/2002	US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002	US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002	US20020164690 Receptor based antagonists and methods of making and using
11/07/2002	US20020164685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infectious diseases
11/07/2002	US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002	US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002	US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002	US20020164642 Pool of immunoglobulin polypeptides for use in treating and preventing, inflammation, allergies, cancer, bacterial or viral infection, diabetes, arthritis, myasthenia gravis and autoimmune diseases
11/07/2002	US20020164618 Enzymes having high temperature polymerase activity and methods of use thereof
11/07/2002	US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
11/07/2002	US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002	US20020164595 Sequence specific DNA binding by p53
11/07/2002	US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002	US20020164348 Inhibitors of viral infection
11/07/2002	US20020164338 Combined approach to treatment of cancer with hCG vaccines
11/07/2002	US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002	US20020164334 Antibody-induced apoptosis
11/07/2002	US20020164326 Genetic engineering; administering immunoglobulins
11/07/2002	US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002	DE10120835A1 Batch method for preparing antibodies, useful as pharmaceuticals, by culturing cells with exchange of medium and removal of metabolic waste products
11/07/2002	DE10120816A1 New antibody specific for histamine receptor protein, useful for treating or preventing e.g. allergy or inflammation, also antigens for its preparation
11/07/2002	CA2715570A1 Cripto blocking antibodies and uses thereof
11/07/2002	CA2453675A1 Genes and proteins for the biosynthesis of lactimidomycin
11/07/2002	CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002	CA2446010A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002	CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	CA2445945A1 Modified organs and cells for xenotransplantation
11/07/2002	CA2445596A1 Method for replicating the hepatitis c virus
11/07/2002	CA2445367A1 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002	CA2445349A1 Anti-cd40 monoclonal antibody
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2439199A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/06/2002	EP1254962A1 Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins
11/06/2002	EP1254956A2 Novel osteoinductive compositions
11/06/2002	EP1254952A1 Cells capable of differentiating into heart muscle cells
11/06/2002	EP1254935A2 Gelatins with good slipping properties, processes for their preparation and their uses
11/06/2002	EP1254913A1 Monoclonal antibodies against CK-MB
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254256A2 Novel nucleic acids and polypeptides
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254247A1 Protein and oat beta glucan hydrolysate for use in cosmetology and method for making same
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254245A1 Regulated expression of plac in staphylococcus aureus
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002	EP1254232A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
11/06/2002	EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254216A2 Improved galactosylation of recombinant glycoproteins
11/06/2002	EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
11/06/2002	EP1254175A1 Human cystine knot polypeptide
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254165A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254154A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254150A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1253942A1 Cd40-binding apc-activating molecules
11/06/2002	EP1253941A1 Pre-transplant accommodated organs resistant to anti-donor immunity
11/06/2002	EP1253932A2 Botulinum toxin pharmaceutical compositions
11/06/2002	EP1007718A4 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
11/06/2002	EP1007065A4 Preparation of collagen
11/06/2002	EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
11/06/2002	EP0773959B1 Adrenergic receptor
11/06/2002	EP0757720B1 Trimerising polypeptides, their manufacture and use
11/06/2002	EP0689550B1 Antimicrobial peptides from bovine neutrophils
11/06/2002	CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof
11/06/2002	CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
11/06/2002	CN1378552A Novel transcription factor BP1
11/06/2002	CN1377965A Human peptide transport protein 2 coding sequence, preparing method and use

1 ... 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 ... 1125